SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 112.77 |
| Enterprise Value ($M) | 100.81 |
| Book Value ($M) | 79.97 |
| Book Value / Share | 0.44 |
| Price / Book | 1.41 |
| NCAV ($M) | 10.83 |
| NCAV / Share | 0.06 |
| Price / NCAV | 10.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.45 |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.17 |
| Current Ratio | 5.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.57 |
| Assets | 90.71 |
| Liabilities | 10.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -36.73 |
| Net Income | -32.54 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -29.06 |
| Cash from Investing | 0.00 |
| Cash from Financing | 13.83 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 4.80 | 1.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 341,457 | 1,010,487 | 33.79 | |
| 869,529 | 2,454,342 | 35.43 | |
| 258,567 | 994,845 | 25.99 | |
| 170,267 | 612,545 | 27.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRIS – Curis, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. | CUE – Cue Biopharma, Inc. |
| CVKD – Cadrenal Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io